M.-Pilar Marco

Professor of Research of CSIC (https://www.csic.es/en), Coordinator of the Nanomedicine Research Program of the CIBER-BBN (https://www.ciber-bbn.es/en), Coordinator of the Diagnostic Strategic Initiative of the PTI Salud Global (https://pti-saludglobal-covid19.corp.csic.es/) and Head of the Nanobiotechnology for Diagnostics (Nb4D) group (http://nb4d.iqac.csic.es/nb4d/).

She is a worldwide reference in the field of antibody-based technologies. As Head of the Nb4D group she leads and coordinates a multidisciplinary research group which scientific activity is addressed to develop a new generation of diagnostic approaches based on the integration of tailored bioreceptors with micro(nano)structures and/or innovative optical or electrochemical transducer schemes. Most of her research is performed in the context of international collaborations with different research institutions, companies and other stakeholders. She has co-authored more than 200 articles in international scientific journals of high-impact factor and has placed several patents, some of them under exploitation. She is also the Scientific Director of the Custom Antibody Service (CAbS) a facility of the ICTS NANBIOSIS (https://www.nanbiosis.es/) that aims to provide support and services to research groups and companies in all aspects related to antibody production and use on different application fields.